Heart Dose Is an Independent Dosimetric Predictor of Overall Survival in Locally Advanced Non–Small Cell Lung Cancer-Reference-Cited by-同舟云学术

Heart Dose Is an Independent Dosimetric Predictor of Overall Survival in Locally Advanced Non–Small Cell Lung Cancer

Published:2017-02 Issue:2 Volume:12 Page:293-301
ISSN:1556-0864
Container-title:Journal of Thoracic Oncology
language:en
Short-container-title:Journal of Thoracic Oncology

Author:

Speirs Christina K.,DeWees Todd A.,Rehman Sana,Molotievschi Alerson,Velez Maria A.,Mullen Daniel,Fergus Sandra,Trovo Marco,Bradley Jeffrey D.,Robinson Cliff G.

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine,Oncology

Reference23 articles.

1. Improved survival in stage III non-small-cell lung cancer: seven-year follow-up of cancer and leukemia group B (CALGB) 8433 trial;Dillman;J Natl Cancer Inst,1996

2. Follow-up of non-small cell lung cancer. American College of Radiology. ACR Appropriateness Criteria;Sause;Radiology,2000

3. High-dose radiation improved local tumor control and overall survival in patients with inoperable/unresectable non-small-cell lung cancer: long-term results of a radiation dose escalation study;Kong;Int J Radiat Oncol Biol Phys,2005

4. Meta-analysis of concomitant versus sequential radiochemotherapy in locally advanced non-small-cell lung cancer;Aupérin;J Clin Oncol,2010

5. Standard-dose versus high-dose conformal radiotherapy with concurrent and consolidation carboplatin plus paclitaxel with or without cetuximab for patients with stage IIIA or IIIB non-small-cell lung cancer (RTOG 0617): a randomised, two-by-two factorial phase 3 study

Cited by 213 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Blood biomarkers for cardiac damage during and after radiotherapy for esophageal cancer: A prospective cohort study;Radiotherapy and Oncology;2024-11

2. “Mid-P strategy” versus “internal target volume strategy in locally advanced non small cell lung cancer: Clinical results from the randomized non-comparative phase II study Mid-P;Radiotherapy and Oncology;2024-10

3. Cardiac Substructure Dose and Survival in Stereotactic Radiotherapy for Lung Cancer: Results of the Multi-Centre SSBROC Trial;Clinical Oncology;2024-10

4. Intercellular pathways of cancer treatment-related cardiotoxicity and their therapeutic implications: the paradigm of radiotherapy;Pharmacology & Therapeutics;2024-08

5. Biomarkers associated with pulmonary exacerbations in a randomized trial of nintedanib for radiation pneumonitis;Radiotherapy and Oncology;2024-07